CHMP2B-related frontotemporal dementia
Last updated 13 Nov 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
CHMP2B-related frontotemporal dementia is a progressive brain disorder that affects personality, behaviour, and language. The symptoms of this disorder usually become noticeable in a person's fifties or sixties, and affected people survive about 3 to 21 years after the appearance of symptoms.
Video picks for Genetic conditionsVideo library
Description
CHMP2B-related frontotemporal dementia is a progressive brain disorder that affects personality, behaviour, and language. The symptoms of this disorder usually become noticeable in a person's fifties or sixties, and affected people survive about 3 to 21 years after the appearance of symptoms.
Changes in personality and behaviour are the most common early signs of CHMP2B-related frontotemporal dementia. These changes include inappropriate emotional responses, restlessness, loss of initiative, and neglect of personal hygiene. Affected individuals may overeat sweet foods or place non-food items into their mouths (hyperorality). Additionally, it may become difficult for affected individuals to interact with others in a socially appropriate manner. They increasingly require help with personal care and other activities of daily living.
Many people with CHMP2B-related frontotemporal dementia develop progressive problems with speech and language (aphasia). They may have trouble speaking, although they can often understand others' speech and written text. Affected individuals may also have difficulty using numbers (dyscalculia). In the later stages of the disease, many completely lose the ability to communicate.
Several years after signs and symptoms first appear, some people with CHMP2B-related frontotemporal dementia develop problems with movement. These movement abnormalities include rigidity, tremors, uncontrolled muscle tensing (dystonia), and involuntary muscle spasms (myoclonus). As the disease progresses, most affected individuals become unable to walk.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Chromosome 3-linked frontotemporal dementia
DTM1
FTD-3
FTD-CHMP2B
FTD3
Patient picks for Genetic conditions

Brain and nerves
Memory loss and dementia
Memory loss has a number of causes, one of which is dementia. Dementia is a progressive condition which causes deteriorating mental function which interferes with activities of daily living.
by Dr Doug McKechnie, MRCGP

Brain and nerves
What causes dementia?
Dementia is a condition that gets worse over time and causes problems with how our brain functions, particularly memory loss and problems with thinking, learning, reasoning, problem solving, and emotions. This increasingly interferes with activities of daily living - until even basic things such as dressing and eating are affected.
by Dr Colin Tidy, MRCGP

Brain and nerves
What are the different types of dementia?
For many people, dementia means Alzheimer's. But Alzheimer's isn't the only type of dementia; there are actually several different forms. What are the differences and how do doctors diagnose each type?
by Glynis Kozma

Brain and nerves
7 ways to help protect your brain from dementia
According to the Alzheimer's Society, over 980,000 people in the UK are living with dementia - a number that's expected to grow to 1.4 million by 2040. As we live longer, our chance of developing this condition increases. However, lifestyle adjustments and healthy living may help minimise its impact.
by Victoria Raw

Brain and nerves
Causes of memory loss and dementia
Everybody forgets things from time to time. In general, the things that you tend to forget most easily are the things that you feel do not matter as much.
by Dr Doug McKechnie, MRCGP

Brain and nerves
Young-onset dementia - what you need to know
Dementia is often seen as something that only affects us during our twilight years. But it can develop much earlier in life. Young-onset dementia refers to dementia diagnosed before the age of 65. We explore the early signs of young-onset dementia, how it’s identified and treated, and practical ways to manage the condition while maintaining quality of life.
by Victoria Raw
Related patient information and medicines

Patient information leaflet
Memory loss and dementia
Mixed dementia This is a combination of two or more types of dementia; for... Lewy body dementia This is a type of dementia caused by lumps of protein in the brain, called Lewy bodies. Frontotemporal dementia This is a type of dementia that causes the frontal and temporal lobes of the brain to shrink and stop working. Other types of dementia There.

Patient information leaflet
Temporal lobe lesions
A serious head injury Head injuries or a surgical operation to remove a brain tumour may may also cause damage or injury to the temporal lobe. Progressive worsening of language can be part of a type of dementia Memory loss and dementia called frontotemporal dementia. Frontotemporal dementia The temporal lobe can be affected by an infection of the.

Patient information leaflet
Causes of memory loss and dementia
If Lewy bodies develop in a part of the brain called the brain stem, as well as symptoms of... For example, stiffness, slowness of movement and a shuffling walk with difficulty in starting, stopping, and in turning easily. Frontotemporal dementia This tends to affect younger people aged 45-65. The symptoms tend to be changes in personality,.

Patient information leaflet
Can I take Danazol and Quetiapine together?
You will need regular blood tests to monitor your liver function while taking this medicine. Dementia in the elderly Quetiapine must not be used to treat elderly patients with dementia-related psychosis, as it significantly increases the risk of stroke and death in this group. Heart rhythm disorders (Long QT syndrome) Quetiapine can affect your.

Patient information leaflet
Can I take Amlodipine and Quetiapine together?
Your doctor may want to monitor your blood pressure more closely when you first start this combination or if your dose is changed. Important precautions Dementia in elderly patients There is an increased risk of stroke and death when quetiapine used to treat dementia-related psychosis in elderly patients. Suicidal thoughts and self-harm Quetiapine.

Patient information leaflet
Down's syndrome
Down's syndrome (also known as Down syndrome) is a genetic chromosome problem. Someone with Down's syndrome has an extra copy of c... Premature ageing can occur leading to the formation of cataracts Cataracts and age-related hearing problems. Early-onset dementia Memory loss and dementia can occur. People with Down's syndrome don't have an.
Further reading and references
- CHMP2B-related frontotemporal dementia; MedlinePlus, National Library of Medicine.
- Brown J, Ashworth A, Gydesen S, Sorensen A, Rossor M, Hardy J, Collinge J. Familial non-specific dementia maps to chromosome 3. Hum Mol Genet. 1995 Sep;4(9):1625-8. doi: 10.1093/hmg/4.9.1625.
- Brown J, Gydesen S, Johannsen P, Gade A, Skibinski G, Chakrabarti L, Brun A, Spillantini M, Yancopoulou D, Thusgaard T, Sorensen A, Fisher E, Collinge J; FReJA (Frontotemporal Dementia Research in Jutland Association). Frontotemporal dementia linked to chromosome 3. Dement Geriatr Cogn Disord. 2004;17(4):274-6. doi: 10.1159/000077153.
- Brown J. Chromosome 3-linked frontotemporal dementia. Cell Mol Life Sci. 1998 Sep;54(9):925-7. doi: 10.1007/s000180050222.
- Gydesen S, Brown JM, Brun A, Chakrabarti L, Gade A, Johannsen P, Rossor M, Thusgaard T, Grove A, Yancopoulou D, Spillantini MG, Fisher EM, Collinge J, Sorensen SA. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology. 2002 Nov 26;59(10):1585-94. doi: 10.1212/01.wnl.0000034763.54161.1f.
- Holm IE, Englund E, Mackenzie IR, Johannsen P, Isaacs AM. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol. 2007 Oct;66(10):884-91. doi: 10.1097/nen.0b013e3181567f02.
- Lindquist SG, Braedgaard H, Svenstrup K, Isaacs AM, Nielsen JE; FReJA Consortium. Frontotemporal dementia linked to chromosome 3 (FTD-3)--current concepts and the detection of a previously unknown branch of the Danish FTD-3 family. Eur J Neurol. 2008 Jul;15(7):667-70. doi: 10.1111/j.1468-1331.2008.02144.x. Epub 2008 May 15.
- Roos P, Holm IE, Nielsen JE, Ejlerskov P, Toft A, Isaacs AM. CHMP2B-Related Frontotemporal Dementia-Amyotrophic Lateral Sclerosis. 2007 Aug 23 [updated 2026 Mar 25]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1199/
- Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T, Brandner S, Brun A, Rossor MN, Gade A, Johannsen P, Sorensen SA, Gydesen S, Fisher EM, Collinge J. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet. 2005 Aug;37(8):806-8. doi: 10.1038/ng1609. Epub 2005 Jul 24.
- van der Zee J, Urwin H, Engelborghs S, Bruyland M, Vandenberghe R, Dermaut B, De Pooter T, Peeters K, Santens P, De Deyn PP, Fisher EM, Collinge J, Isaacs AM, Van Broeckhoven C. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet. 2008 Jan 15;17(2):313-22. doi: 10.1093/hmg/ddm309. Epub 2007 Oct 22.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

